Efficacy of Hi-tACS for Schizophrenia Negative Symptoms
RecruitingNCT06888726Phase: NAStarted 2024-06-27
Summary
The goal of this clinical trial is to investigate whether Hi-tACS is effective and safe in treating negative symptoms of schizophrenia. Schizophrenic patients will receive treatment (Hi-tACS or shame
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Shanghai Mental Health CenterShanghai, Shanghai Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06888726